DEPAKINE 400 mg/4 ml, preparation injectable for route i.v. bottle, 4 ml
Brand page: Depakine, Depakine Chrono (valproic acid (sodium valproate)) — all forms and strengths in France
Active ingredients: Sodium valproate
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEPAKINE 400 mg/4 mL, préparation injectable pour voie I.V.
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 400 mg - 1 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Nov 2019
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
68206925CIP75506287CIP133400955062875Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (VALPROATE DE)poudre | 400,00 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.